We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-13.57%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$84.5B
AUM Growth
-$745M
Cap. Flow
+$13.7B
Cap. Flow %
16.26%
Top 10 Hldgs %
10.97%
Holding
4,738
New
695
Increased
1,955
Reduced
1,481
Closed
562

Sector Composition

Rank Sector Weight
1 Healthcare 19.41%
2 Technology 16.8%
3 Consumer Staples 11.12%
4 Consumer Discretionary 10.11%
5 Financials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YVR
4126
DELISTED
Liquid Media Group Ltd. Common Shares
YVR
$19K ﹤0.01%
12,113
-44,538
-79% -$89.7K
XMAX
4127
XMAX Inc
XMAX
$548M
$18K ﹤0.01%
5,069
+885
+21% +$4.24K
SNTG icon
4128
Sentage Holdings
SNTG
$4.6M
$18K ﹤0.01%
5,860
+3,380
+136% +$12K
VERO
4129
DELISTED
Venus Concept
VERO
$18K ﹤0.01%
+232
New +$32.7K
FRES
4130
DELISTED
Fresh2 Group Limited American Depositary Shares
FRES
$18K ﹤0.01%
+312
New +$20.9K
DMS
4131
DELISTED
Digital Media Solutions, Inc.
DMS
$18K ﹤0.01%
+1,100
New +$37.2K
VYNT
4132
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$18K ﹤0.01%
4,060
+178
+5% +$781
CUEN
4133
DELISTED
Cuentas Inc. Common Stock
CUEN
$18K ﹤0.01%
+2,208
New +$25.2K
IPW icon
4134
iPower
IPW
$958K
$17K ﹤0.01%
65
-86
-57% -$26.6K
VVOS icon
4135
Vivos Therapeutics
VVOS
$5.7M
$17K ﹤0.01%
516
+80
+18% +$3.32K
AEY
4136
DELISTED
ADDvantage Technologies Group
AEY
$17K ﹤0.01%
+1,320
New +$16.7K
PHCF
4137
DELISTED
Puhui Wealth Investment Management Co., Ltd.
PHCF
$17K ﹤0.01%
4,400
-750
-15% -$3.09K
CLPS icon
4138
CLPS Inc
CLPS
$25.6M
$16K ﹤0.01%
+10,432
New +$18.7K
SNES icon
4139
SenesTech
SNES
$7.16M
$16K ﹤0.01%
13
+8
+160% +$11K
BLCM
4140
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$16K ﹤0.01%
+13,400
New +$20.2K
AIRI icon
4141
Air Industries Group
AIRI
$13M
$15K ﹤0.01%
+2,150
New +$15.8K
IFBD icon
4142
Infobird
IFBD
$8.52M
$15K ﹤0.01%
8
-10
-56% -$25.7K
BIMI
4143
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
$15K ﹤0.01%
2,390
-14,291
-86% -$112K
TPHS
4144
DELISTED
Trinity Place Holdings Inc.com
TPHS
$15K ﹤0.01%
14,907
-8,022
-35% -$10.5K
REED
4145
DELISTED
Reeds, Inc. Common Stock
REED
$15K ﹤0.01%
1,936
-1,535
-44% -$16.8K
CEMI
4146
DELISTED
Chembio diagnostics, Inc.
CEMI
$15K ﹤0.01%
+23,500
New +$15.6K
ONCY
4147
Oncolytics Biotech
ONCY
$89.9M
$14K ﹤0.01%
14,000
-11,500
-45% -$14K
PALI icon
4148
Palisade Bio
PALI
$330M
$14K ﹤0.01%
46
+18
+64% +$8.67K
CRKN
4149
DELISTED
Crown Electrokinetics Corp. Common Stock
CRKN
0
BETS
4150
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
$14K ﹤0.01%
3
-16
-84% -$80.7K

Similar funds

Renaissance Technologies's Q2 2022 Portfolio in Review

As of Q2 2022, Renaissance Technologies held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies deployed $13.7B of net new capital in Q2 2022, opening 695 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.

  • Renaissance Technologies's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
  • Renaissance Technologies added most to Chevron in Q2 2022, an estimated $820M increase.
  • Renaissance Technologies's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
  • Renaissance Technologies fully exited Amazon in Q2 2022, selling an estimated $675M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
  • Renaissance Technologies opened 695 new positions and closed 562 in Q2 2022.
  • Renaissance Technologies's portfolio value fell 0.87% quarter-over-quarter to $84.5B.

Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.